Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Inspire Medical Systems (INSP) over the last 7 years, with Q4 2025 value amounting to $29.8 million.

  • Inspire Medical Systems' Shares Outstanding (Diluted Average) fell 257.42% to $29.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.8 million, marking a year-over-year decrease of 257.42%. This contributed to the annual value of $29.8 million for FY2025, which is 257.42% down from last year.
  • Per Inspire Medical Systems' latest filing, its Shares Outstanding (Diluted Average) stood at $29.8 million for Q4 2025, which was down 257.42% from $29.9 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Shares Outstanding (Diluted Average) ranged from a high of $30.6 million in Q3 2024 and a low of $27.1 million during Q1 2021
  • For the 5-year period, Inspire Medical Systems' Shares Outstanding (Diluted Average) averaged around $28.9 million, with its median value being $29.3 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 592.52% in 2023, then tumbled by 264.53% in 2025.
  • Inspire Medical Systems' Shares Outstanding (Diluted Average) (Quarter) stood at $27.3 million in 2021, then rose by 2.97% to $28.1 million in 2022, then rose by 4.38% to $29.3 million in 2023, then grew by 4.24% to $30.5 million in 2024, then fell by 2.57% to $29.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $29.8 million for Q4 2025, versus $29.9 million for Q3 2025 and $29.6 million for Q2 2025.